[Form 4] Regional Health Properties, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Gene E. Burleson, a director of Regional Health Properties, Inc. (RHE), reported insider transactions dated 08/29/2025. The filing shows a purchase of 5,000 common shares at $1.99 per share, increasing his reported beneficial ownership to 5,000 shares held indirectly by The Burleson Family Foundation. The form also reports dispositions and existing indirect holdings: 3,253 common shares disposed, 22 common shares held indirectly by an IRA, and 13,606 common shares held indirectly by the Eugene E. Burleson Family Trust (spouse as trustee). For Series D 8% Cumulative Convertible Redeemable Preferred Shares, 2,871 were disposed and 12,009 are held indirectly by the Eugene E. Burleson Family Trust, with 20 held indirectly by an IRA. The form is signed 09/03/2025.

Positive

• Director purchased 5,000 common shares at $1.99 on 08/29/2025, signaling insider buy activity
• Insider continues to hold significant indirect positions via the Eugene E. Burleson Family Trust (13,606 common; 12,009 Series D preferred)

Negative

• Reported dispositions of 3,253 common shares and 2,871 Series D preferred shares reduce direct/indirect holdings
• Form lacks company total shares outstanding, so the materiality of these trades relative to overall capitalization is unclear

Insights

Securities Analyst

TL;DR: Director reported a small open-market purchase and several disposals across common and Series D preferred holdings; impact appears limited.

Gene Burleson bought 5,000 common shares at $1.99 and retains material indirect holdings through family trusts and an IRA. The filing records disposals of 3,253 common shares and 2,871 Series D preferred shares, while sizable indirect holdings remain (13,606 common; 12,009 Series D preferred). Without company-wide share counts or context on ownership percentages, these transactions are informative about insider activity but do not on their own indicate a material change to control or capital structure.

Corporate Governance Expert

TL;DR: Reported trades show routine insider rebalancing among personal, trust and IRA accounts; no clear governance red flags.

The report identifies the reporting person as a director and details transfers and purchases involving family entities and retirement accounts. The mix of acquisitions and dispositions, and the involvement of trusts and an IRA, are consistent with estate planning or portfolio rebalancing rather than single-event corporate actions. The signature and Rule 16 reporting satisfy disclosure requirements; there is no indication of undisclosed related-party transactions within this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BURLESON GENE E

(Last) (First) (Middle)

C/O REGIONAL HEALTH PROPERTIES, INC.

1050 CROWN POINTE PARKWAY, SUITE 720

(Street)

ATLANTA GA 30338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
REGIONAL HEALTH PROPERTIES, INC [ RHEP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/29/2025		P		5,000	A	$1.99	5,000	I	The Burleson Family Foundation
Common Stock								3,253	D
Common Stock								22	I	By IRA
Common Stock								13,606	I	Eugene E. Burleson Family Trust; Spouse as Trustee
Series D 8% Cumulative Conver. Redeemable Preferred Shares								2,871	D
Series D 8% Cumulative Conver. Redeemable Preferred Shares								20	I	By IRA
Series D 8% Cumulative Conver. Redeemable Preferred Shares								12,009	I	Eugene E. Burleson Family Trust; Spouse as Trustee

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Gene E. Burleson	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did RHE insider Gene Burleson trade on 08/29/2025?

He acquired 5,000 common shares at $1.99 per share and the filing also reports certain dispositions of common and Series D preferred shares.

How much common stock does Gene Burleson beneficially own after the reported transactions?

The form reports 5,000 common shares beneficially owned following the reported purchase; additional indirect holdings include 13,606 common shares held by the Eugene E. Burleson Family Trust and 22 shares held by an IRA.

What preferred holdings were reported by the insider in the Form 4?

The filing shows 12,009 Series D 8% cumulative convertible redeemable preferred shares held indirectly by the Eugene E. Burleson Family Trust, 20 Series D shares held by an IRA, and a reported disposition of 2,871 Series D shares.

Is this Form 4 filing compliant and signed?

Yes, the filing is signed by /s/ Gene E. Burleson with a signature date of 09/03/2025.

Does the Form 4 indicate a change in control of RHE?

No. The filing reports purchases and dispositions by a director and family entities but does not indicate any change in control or ownership percentage that would alter corporate control.